THY1 and non-small cell lung carcinoma: Fibroblast activation markers FAP, CD29, αSMA, PDPN, CD90, FSP1 and PDGFRβ expression levels were determined and compared for tumour and non-cancerous adjacent lung tissue from NSCLC patients by looking at the percentage positivity for each marker (Fig. 1b).